|
USANA Health Sciences, Inc. (USNA) DCF -Bewertung |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
USANA Health Sciences, Inc. (USNA) Bundle
Möchten Sie den inneren Wert von Usana Health Sciences, Inc. beurteilen? Unser USNA DCF-Taschenrechner integriert reale Daten mit umfassenden Anpassungsfunktionen, sodass Sie Ihre Prognosen verfeinern und Ihre Investitionsauswahl verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,134.6 | 1,186.5 | 998.6 | 921.0 | 854.5 | 798.4 | 746.0 | 697.0 | 651.3 | 608.5 |
| Revenue Growth, % | 0 | 4.57 | -15.83 | -7.77 | -7.22 | -6.56 | -6.56 | -6.56 | -6.56 | -6.56 |
| EBITDA | 201.0 | 192.9 | 130.2 | 123.1 | 98.9 | 114.9 | 107.3 | 100.3 | 93.7 | 87.6 |
| EBITDA, % | 17.71 | 16.26 | 13.04 | 13.37 | 11.57 | 14.39 | 14.39 | 14.39 | 14.39 | 14.39 |
| Depreciation | 22.5 | 22.2 | 21.4 | 20.4 | 22.2 | 17.3 | 16.1 | 15.1 | 14.1 | 13.2 |
| Depreciation, % | 1.98 | 1.87 | 2.14 | 2.21 | 2.6 | 2.16 | 2.16 | 2.16 | 2.16 | 2.16 |
| EBIT | 178.5 | 170.7 | 108.8 | 102.7 | 76.6 | 97.6 | 91.2 | 85.2 | 79.6 | 74.4 |
| EBIT, % | 15.73 | 14.39 | 10.9 | 11.15 | 8.97 | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 |
| Total Cash | 311.9 | 239.8 | 288.4 | 330.4 | 181.8 | 213.5 | 199.5 | 186.4 | 174.2 | 162.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.4 | 7.2 | 7.2 | 7.2 | .0 | 4.4 | 4.1 | 3.9 | 3.6 | 3.4 |
| Account Receivables, % | 0.65395 | 0.60373 | 0.72231 | 0.78186 | 0 | 0.55237 | 0.55237 | 0.55237 | 0.55237 | 0.55237 |
| Inventories | 90.2 | 98.3 | 67.1 | 61.5 | 69.7 | 60.3 | 56.4 | 52.7 | 49.2 | 46.0 |
| Inventories, % | 7.95 | 8.29 | 6.72 | 6.67 | 8.16 | 7.56 | 7.56 | 7.56 | 7.56 | 7.56 |
| Accounts Payable | 18.2 | 13.5 | 11.0 | 10.1 | 12.0 | 10.1 | 9.5 | 8.8 | 8.3 | 7.7 |
| Accounts Payable, % | 1.6 | 1.14 | 1.11 | 1.09 | 1.4 | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 |
| Capital Expenditure | -15.1 | -12.8 | -10.4 | -14.5 | -10.1 | -9.9 | -9.3 | -8.6 | -8.1 | -7.5 |
| Capital Expenditure, % | -1.33 | -1.08 | -1.04 | -1.57 | -1.18 | -1.24 | -1.24 | -1.24 | -1.24 | -1.24 |
| Tax Rate, % | 44.95 | 44.95 | 44.95 | 44.95 | 44.95 | 44.95 | 44.95 | 44.95 | 44.95 | 44.95 |
| EBITAT | 125.0 | 116.5 | 69.5 | 64.0 | 42.2 | 62.4 | 58.3 | 54.5 | 50.9 | 47.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 53.0 | 113.4 | 109.2 | 74.5 | 55.2 | 72.9 | 68.7 | 64.2 | 60.0 | 56.1 |
| WACC, % | 8.61 | 8.61 | 8.6 | 8.6 | 8.58 | 8.6 | 8.6 | 8.6 | 8.6 | 8.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 255.8 | |||||||||
| Long Term Growth Rate, % | 0.50 | |||||||||
| Free cash flow (T + 1) | 56 | |||||||||
| Terminal Value | 696 | |||||||||
| Present Terminal Value | 461 | |||||||||
| Enterprise Value | 716 | |||||||||
| Net Debt | -159 | |||||||||
| Equity Value | 875 | |||||||||
| Diluted Shares Outstanding, MM | 19 | |||||||||
| Equity Value Per Share | 45.67 |
What You Will Get
- Real USNA Financial Data: Pre-filled with USANA’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See USANA’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: USANA Health Sciences, Inc.'s historical financial statements and pre-populated projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Valuation: Observe USANA's intrinsic value update instantly as you adjust inputs.
- Intuitive Visualizations: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review USANA Health Sciences, Inc.'s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust assumptions.
- Step 5: Analyze the outputs and leverage the results for investment decisions.
Why Choose This Calculator for USANA Health Sciences, Inc. (USNA)?
- Accuracy: Utilizes real USANA financials for precise data representation.
- Flexibility: Tailored for users to easily adjust and experiment with inputs.
- Time-Saving: Avoid the complexity of constructing a financial model from the ground up.
- Professional-Grade: Crafted with the insight and precision expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with varying financial expertise.
Who Should Use This Product?
- Investors: Accurately estimate USANA Health Sciences, Inc.'s (USNA) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to USANA (USNA).
- Consultants: Quickly adapt the template for valuation reports tailored to USANA (USNA) clients.
- Entrepreneurs: Gain insights into financial modeling practices used by leading health and wellness companies like USANA (USNA).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to the health sciences sector, including USANA (USNA).
What the Template Contains
- Pre-Filled Data: Includes USANA Health Sciences’ historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze USANA’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.